LUDWIG VON SALLMANN, M.D.; HERBERT E. KAUFMAN, M.D.; GUNTER R. HAASE, M.D.; FREDERIC C. BARTTER, M.D.; Louis B. THOMAS, M.D.
Dr. Ludwig Von Sallmann: We have selected primary amyloidosis as our subject today for several reasons. In recent years a certain type of vitreous opacification has been recognized as being due to amyloidosis, with characteristics which distinguish this lesion from other types of vitreous opacities. Also, this form of vitreous change provides the opportunity to diagnose a systemic disease of protean symptomatology often undiagnosed during life. Finally, experts in this field are willing to participate in the discussion from other than the ophthalmologic viewpoint.
Dr. Herbert E. Kaufman has done considerable work in tracing members of families who have died
VON SALLMANN L, KAUFMAN HE, HAASE GR, et al. PRIMARY AMYLOIDOSIS: CLINICAL STAFF CONFERENCE AT THE NATIONAL INSTITUTES OF HEALTH*. Ann Intern Med. 1960;52:668–681. doi: https://doi.org/10.7326/0003-4819-52-3-668
Download citation file:
Published: Ann Intern Med. 1960;52(3):668-681.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use